Allied Market Research
Loading...
0
Upcoming Allied Market Research
2021
Vasopressin For Vasoplegic Shock Market

Vasopressin for Vasoplegic Shock Market, by Type (Intravenous Injection, Intramuscular Injection, and Subcutaneous Injection) and Application (Sepsis, Post Cardiac Surgery, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030

A13248
Pages: NA
Nov 2021 | 37 Views
   
Author(s) : Onkar Sumant
Tables: NA
Charts: NA
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • IComes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Vasopressin For Vasoplegic Shock Market

Request Now !

Vasopressin for Vasoplegic Shock Market Overview 2030

Vasopressin is a peptide hormone used to increase blood pressure levels in patients with vasoplegic shocks that occur post cardiac surgeries. Vasopressin is a drug used for treatment of diabetes insipidus, which is caused due to absence of pituitary hormone in the body. In clinical models of cardiac arrests and related syndromes, vasopressin pumps blood in the heart and brain, thus improving long-term survival chances. Apart from this, vasopressin finds application in the treatment of gastro intestinal bleeding and ventricular defibrillation. Various conducted trials have shown that infusion of vasopressin to such patients increases the systemic vascular resistance levels against vasoplegic shocks. Vasopressin increases the arterial pressure in patients, thus providing better survival chances.

Vasoplegic is a pathological syndrome exhibiting low vascular resistance. This further leads to reduced blood pressure levels. Additionally, one of the possible outcomes of COVID-19 pandemic include cardiac syndromes risks, thus pushing for enhanced demand for vasopressin drugs. The global pharmaceutical players are eyeing higher investments to develop advanced vasopressin. This includes market strategies such as collaborations, acquisitions, and mergers in an attempt to gain significant competitive edge over competitors during the forecasted period. Additionally, companies are looking at higher brand reputation in the market place by achieving cost leadership through manufacturing the drug at cheaper rates and selling them through effective and efficient distribution channel system, making use of agile techniques.

Market Scope and Structure Analysis

Report Metric

Details

 Market Size Available for Years

 2020–2030

 Base Year Considered

 2020

 Forecast Period

 2021–2030

 Forecast Unit

 Value (USD)

 Segments Covered

 Types, Applications, and Region

 Regions Covered

 North America, Europe, Asia-Pacific, and LAMEA

 Companies Covered

Avadel, CSL Limited, Ferring B.V., Novartis AG, Sanofi, ENDO International, Pfizer, Astellas Pharma, La Jolla Pharmaceuticals, AMOMED Pharma

 

COVID-19 Impact Analysis

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industries are expected to witness a significant growth in the future, owing to the demand for vaccine and treatment drugs for COVID-19. This, in turn, is expected to have a significant impact on the vasopressin for vasoplegic  market.

Top Impacting Factors

Growing concern of cardiac related syndromes in COVID-19 patients is bound to increase sales of vasopressin.

The ever-increasing growth of pilot studies in the sphere of appraising efficacy of vasopressin against vasoplegic shocks provides a strong case for two-fold market expansion.

Increasing numbers of cardiac surgeries especially in Asia-Pacific is a factor leading to exponential demand for this drug. As per the reports of the North American Cardiac Surgery Working Group, a total of 60,452 cardiac surgeries were performed in 2019 alone .

Countries with higher ageing populations such as China and India are at higher risk of sepsis incidences, thus stimulating the growth of vasopressin.

However, higher intake of vasopressin may lead to higher water levels in kidney leading to unbalanced antidiuretic hormone secretion (ADH), which might act as a restraining factor for the market.

Key Market Trends

Increase in cases of sepsis in North America is expected to offer remunerative opportunities for the market expansion in the region.

Similarly, encouraging government policies all across Europe coupled with steady private sector investments in the sector boost the growth of the vasopressin market across the continent.

Third world economies, such as India, are witnessing exponential rise in vasopressin for vasoplegic shock market, owing to tier-2 and tier-3 independent manufacturers entering the market against global players.

The latest surviving sepsis campaign guidelines now consider that the best therapeutic management of vasoplegic shocks include a multimodal approach consisting of several vasopressors consisting of early prescription of vasopressin coupled with norepinephrine.

In the latest VANISH study, terlipressin, a vasopressin analog with V1 receptor activity has been proposed as the second line of defense against vasoplegic shocks. However, early clinical trials showcase that terlipressin is not shown to offer a greater advantage over vasopressin, due to its longer half-life, thus, two novel potential drugs namely selepressin and angiotensin II are being accessed instead.

Key Segments Covered

Segment

Subsegment

 Types

  • Intravenous Injection
  • Intramuscular Injection
  •  Subcutaneous Injection

 Applications

  • Sepsis
  •  Post Cardiac Surgery
  •  Others

 Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

 

Key Benefits of the Report

  • This study presents the analytical depiction of the vasopressin for vasoplegic shock market along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the vasopressin for vasoplegic shock market share.
  • The current market is quantitatively analyzed from 2020 to 2030 to highlight the market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed analysis depending on competitive intensity and how the competition will take shape in the coming years.

Questions Answered in the Adenovirus Diagnostic Testing Report

  • Which are the leading players active in the vasopressin for vasoplegic shock market?
  • How is each segment of the market expected to grow during the forecast period?
  • What are the adoption trends for the vasopressin for vasoplegic shock market in emerging economies and established economies across the world?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities of the market?
  • What future projections would help in taking further strategic steps?
  • What are the impacts of COVID-19 in the industry?
  • What is vasopressin for vasoplegic shock market?
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
PURCHASE OPTIONS

Start reading ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

U.S.-Canada
Toll-free :
+1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
 
Allied Market Research Allied Market Research Allied Market Research

Access from any device, anywhere

Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

FREQUENTLY ASKED
QUESTIONS?

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

REQUEST TOC/SAMPLE

OR

Purchase Full Report of
Vasopressin For Vasoplegic Shock Market

Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,456  $3,110
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840  $3,456
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769  $5,192
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450  $5,805
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $9,995  $8,996
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2017-2023

Published in Nov 2017

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers